Evidence map›Paper›PMID 41569270›Full record

GuidelineInfection control and hospital epidemiology2025

2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Post-exposure Prophylaxis in Healthcare Settings.

Aaron D Kofman, Kimberly A Struble, Walid Heneine, Britt Gayle, Marie A de Perio, Devon L Okasako-Schmucker, Christine N So, Laura E Anderson, Erin C Stone, David K Henderson and 1 more

Abstract readPractice GuidelineReview
In one paragraph

Guideline in Infection control and hospital epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Development of a Layperson Injector Training for the Home-Based Administration of Long-Acting Injectable Antiretroviral Therapies for Persons With HIV.AIDS education and prevention : official publication of the International Society for AIDS Education · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aaron D KofmanDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0002-7507-6355
Kimberly A Struble *Division of Antiviral Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.ORCID 0000-0001-9618-0875
Walid HeneineDivision of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0003-3119-3565
Britt GayleHIV/AIDS Bureau, The Health Resources and Services Administration, Rockville, MD, USA.ORCID 0000-0001-5729-6090
Marie A de PerioOffice of the Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, OH, USA.ORCID 0000-0001-5100-8422
Devon L Okasako-SchmuckerDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0001-8227-0263
Christine N SoDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0002-0806-1604
Laura E AndersonDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0009-0008-8517-1939
Erin C StoneDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0001-5458-6308
David K HendersonHospital Epidemiology Service Clinical Center, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-1589-8813
David T KuharDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0003-4208-0101

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

These guidelines update the 2013 "Updated US Public Health Service (PHS) Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis," hereafter referred to as the 2013 PHS Guidelines.

Indexed as

HIV InfectionsInfectious Disease Transmission, Patient-to-ProfessionalOccupational ExposurePost-Exposure ProphylaxisAnti-HIV AgentsHealth PersonnelHumansUnited StatesUnited States Public Health ServiceAnti-HIV Agents

Identifiers

PMID41569270
PMCPMC12616222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.